Imiglucerase and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Determining the interaction of Imiglucerase and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Imiglucerase-Kitabis Pak
- Imiglucerase-Kitabis Pak inhalation
- Imiglucerase-Klofensaid II
- Imiglucerase-Klonopin
- Imiglucerase-Klonopin Wafer
- Imiglucerase-Klonopin Wafers
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imiglucerase Intravenous
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imipenem and cilastatin
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imipenem and Cilastatin Injection
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imipenem and cilastatin Intravenous, Intramuscular
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imipenem, Cilastatin, and Relebactam
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Imipramine